Pharma is becoming increasingly “tailor-made”
Posted: Sun Jan 12, 2025 4:07 am
For some time now, in addition to "humans" (with their devices), objects have also become increasingly interconnected online . Translated: a new enormous amount of data. This is what is meant by IoT (Internet of Things). The result is that today companies have at their disposal , for the first time in history , an almost infinite amount of information on both their processes and their consumers .
The challenge is to collect this information, but – above all – to interpret it in albania phone data a way that makes your business more efficient, from production to distribution, right through to marketing and Customer Care , and this is what all the leading pharmaceutical companies are doing, and they are even going further, using Big Data analysis to improve the quality of their products , keep side effects and their diffusion under control , monitor and make the distribution network more efficient , evaluate the life stages of drugs and patient reactions (on a small or very large scale).
Then there is the whole delicate aspect of the so-called risk management and , last but not least, the decisive aspect of commercial and marketing signals . In short, all the challenges of innovation, of the market and of reputation, in the pharmaceutical sector, are won or lost on the basis of the ability to analyze the data.
In this sense, what is the frontier? The answer is “ precision medicine ”, a theme that immediately brings us to the next point, dedicated to personalization.
For Pharma companies, having an ever-increasing amount of data available means increasing the precision of decisions, but also , and above all, the knowledge of patients : right down to the individual, with their specific problems, their behaviors, their needs .
The challenge is to collect this information, but – above all – to interpret it in albania phone data a way that makes your business more efficient, from production to distribution, right through to marketing and Customer Care , and this is what all the leading pharmaceutical companies are doing, and they are even going further, using Big Data analysis to improve the quality of their products , keep side effects and their diffusion under control , monitor and make the distribution network more efficient , evaluate the life stages of drugs and patient reactions (on a small or very large scale).
Then there is the whole delicate aspect of the so-called risk management and , last but not least, the decisive aspect of commercial and marketing signals . In short, all the challenges of innovation, of the market and of reputation, in the pharmaceutical sector, are won or lost on the basis of the ability to analyze the data.
In this sense, what is the frontier? The answer is “ precision medicine ”, a theme that immediately brings us to the next point, dedicated to personalization.
For Pharma companies, having an ever-increasing amount of data available means increasing the precision of decisions, but also , and above all, the knowledge of patients : right down to the individual, with their specific problems, their behaviors, their needs .